238 related articles for article (PubMed ID: 8213634)
1. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
Ordi J; Grau JM; Junqué A; Nomdedeu B; Palacin A; Cardesa A
Am J Clin Pathol; 1993 Oct; 100(4):394-7. PubMed ID: 8213634
[TBL] [Abstract][Full Text] [Related]
2. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.
Ikeda S; Chisuwa H; Kawasaki S; Ozawa J; Hoshii Y; Yokota T; Aoi T
J Clin Pathol; 1997 Nov; 50(11):965-7. PubMed ID: 9462253
[TBL] [Abstract][Full Text] [Related]
3. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
[TBL] [Abstract][Full Text] [Related]
4. An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.
Morita-Hoshi Y; Tohda S; Miura O; Nara N
Int J Hematol; 2008 Jan; 87(1):69-74. PubMed ID: 18224416
[TBL] [Abstract][Full Text] [Related]
5. Secondary amyloidosis associated with Castleman's disease.
Tanaka K; Horita M; Shibayama H; Seike M; Itoh Y; Hamaguchi K; Sato Y; Sakata T; Ishida T
Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
[TBL] [Abstract][Full Text] [Related]
6. Remission of nephrotic syndrome after removal of localized Castleman's disease.
Keven K; Nergizoğlu G; Ateş K; Erekul S; Orhan D; Ertürk S; Tulunay O; Karatan O; Ertuğ AE
Am J Kidney Dis; 2000 Jun; 35(6):1207-11. PubMed ID: 10845836
[TBL] [Abstract][Full Text] [Related]
7. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.
Yamagata N; Fujio J; Hirai R; Matsumaru M; Tanimura S; Inokuchi C; Shikai T; Takezako N; Nasu M; Sakata Y; Sata N; Nagai H; Saito K; Miwa A
Int J Hematol; 2006 Jul; 84(1):70-3. PubMed ID: 16867906
[TBL] [Abstract][Full Text] [Related]
8. Fatal diarrhea in a patient with Castleman's disease associated with intestinal amyloidosis.
Miura A; Sato I; Suzuki C
Intern Med; 1995 Nov; 34(11):1106-9. PubMed ID: 8774974
[TBL] [Abstract][Full Text] [Related]
9. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease.
Lachmann HJ; Gilbertson JA; Gillmore JD; Hawkins PN; Pepys MB
QJM; 2002 Apr; 95(4):211-8. PubMed ID: 11937647
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotic Syndrome Caused by AA Amyloidosis Secondary to Unicentric Castleman's Disease:Report of One Case].
You RL; Wen YB; Wang J; Ma J; Chen LM; Li XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):540-544. PubMed ID: 35791957
[TBL] [Abstract][Full Text] [Related]
11. Report of six kidney disease-associated Castleman's disease cases.
Sui Y; Zhao D
Clin Nephrol; 2015 Dec; 84(6):344-52. PubMed ID: 26445003
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
[TBL] [Abstract][Full Text] [Related]
13. Angiofollicular lymph node hyperplasia with amyloidosis.
West KP; Morgan DR; Lauder I
Postgrad Med J; 1989 Feb; 65(760):108-11. PubMed ID: 2780459
[TBL] [Abstract][Full Text] [Related]
14. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
Paydas S; Gonlusen G; Sagliker Y
Nephron; 1995; 71(4):463-4. PubMed ID: 8587630
[No Abstract] [Full Text] [Related]
15. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease.
Perfetti V; Bellotti V; Maggi A; Arbustini E; De Benedetti F; Paulli M; Marinone MG; Merlini G
Am J Hematol; 1994 Jul; 46(3):189-93. PubMed ID: 7910717
[TBL] [Abstract][Full Text] [Related]
16. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations.
Curioni S; D'Amico M; Quartagno R; Martino S; Dell'Antonio G; Cusi D
Nephrol Dial Transplant; 2001 Jul; 16(7):1475-8. PubMed ID: 11427644
[No Abstract] [Full Text] [Related]
17. Castleman's disease with renal amyloidosis and nephrotic syndrome.
Arinsoy T; Yilmaz M; Ataoğlu O; Bali M; Sindel S
Nephrol Dial Transplant; 1997 Dec; 12(12):2713-6. PubMed ID: 9430878
[No Abstract] [Full Text] [Related]
18. Mesenteric Castleman's disease in a 12-year-old girl.
Li FF; Zhang T; Bai YZ
J Gastrointest Surg; 2011 Oct; 15(10):1896-8. PubMed ID: 21557018
[TBL] [Abstract][Full Text] [Related]
19. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
[TBL] [Abstract][Full Text] [Related]
20. Multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia.
Hattori K; Irie S; Isobe Y; Wakiya M; Matsumoto T; Suda K; Funabiki K; Tomino Y; Hirano T; Oshimi K
Ann Hematol; 1998 Oct; 77(4):179-81. PubMed ID: 9829851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
